Table 3.
No. (%) | OR (95% CI) P value |
|||||
---|---|---|---|---|---|---|
Outcome | Control | Non-ESBL | ESBL | Non-ESBL vs. Control | ESBL vs. Control | ESBL vs. Non-ESBL |
30-day mortality | 27 (5.5) | 11 (2.2) | 11 (2.2) | 0.36 (0.17-0.77) p=0.009 |
0.41 (0.20-0.82) p=0.01 |
1.00 (0.42-2.40) p=1.00 |
1-year mortality | 72 (14.6) | 46 (9.3) | 56 (11.4) | 0.58 (0.39-0.88) p=0.009 |
0.74 (0.50-1.08) p=0.12 |
1.26 (0.83-1.93) p=0.28 |
Post-culture LOS, days, median (range)a | -- | 11 (0-419) | 22 (0-985) | -- | -- | p=0.001 |
90-day hospital readmissiona | 28 (5.7) | 50 (10.2) | 66 (13.4) | 2.00 (1.20-3.34) p=0.008 |
3.38 (1.93-5.90) p<0.001 |
1.44 (0.94-2.21) p=0.09 |
OR, odds ratio; CI, confidence interval; ESBL, extended-spectrum beta-lactamase; LOS, length of stay
For inpatients only